Blood pressure and mortality in long-term hemodialysis-time to move forward

Panagiotis I. Georgianos, Rajiv Agarwal

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

Contrary to the direct, graded, and causal relationship of hypertension with cardiovascular outcomes in the general population, among dialysis patients, blood pressure (BP) recorded either predialysis or postdialysis displays a U-shaped curve with mortality. This paradoxical phenomenon of lower BP or a decline in BP over time being associated with increased mortality and higher BP being associated with a lower mortality is described as reverse epidemiology of hypertension, raising substantial controversy on whether BP lowering causes harms or benefits among dialysis patients. Unlike the inverse relationship of peridialytic BP with mortality, elevated BP recorded outside of dialysis is directly associated with poor long-term outcomes. Apart from the timing and technique of BP measurement, the U-shaped association of BP with mortality is also modified when accounting for factors related to patient's clinical characteristics and level of illness, dialysis practices, and patterns as well as factors related to the methodology of survival analysis. Most importantly, deliberate BP lowering with antihypertensive drugs is associated with reduced cardiovascular morbidity and mortality. In this review, we explore the complex association of peridialytic, intradialytic, and interdialytic BP with outcomes among dialysis patients. We conclude with recommendations for a wider use of out-of-dialysis BP monitoring as a tool to better evaluate the cardiovascular risk and optimize the management of hypertension in this high-risk population. Rather than more cohort studies, we call for randomized trials to test the level of BP in dialysis patients that is optimal for cardiovascular outcomes.

Original languageEnglish (US)
Pages (from-to)211-222
Number of pages12
JournalAmerican Journal of Hypertension
Volume30
Issue number3
DOIs
StatePublished - 2017

Fingerprint

Renal Dialysis
Blood Pressure
Mortality
Dialysis
Hypertension
Risk Management
Survival Analysis
Antihypertensive Agents
Population
Epidemiology
Cohort Studies
Morbidity

Keywords

  • Ambulatory blood pressure monitoring
  • Blood pressure
  • Dialysis
  • Epidemiology
  • Hypertension
  • Morbidity
  • Mortality
  • Randomized controlled trials

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Blood pressure and mortality in long-term hemodialysis-time to move forward. / Georgianos, Panagiotis I.; Agarwal, Rajiv.

In: American Journal of Hypertension, Vol. 30, No. 3, 2017, p. 211-222.

Research output: Contribution to journalReview article

@article{be3ca484e1bd4c1ca4ccb9b5a8f67c09,
title = "Blood pressure and mortality in long-term hemodialysis-time to move forward",
abstract = "Contrary to the direct, graded, and causal relationship of hypertension with cardiovascular outcomes in the general population, among dialysis patients, blood pressure (BP) recorded either predialysis or postdialysis displays a U-shaped curve with mortality. This paradoxical phenomenon of lower BP or a decline in BP over time being associated with increased mortality and higher BP being associated with a lower mortality is described as reverse epidemiology of hypertension, raising substantial controversy on whether BP lowering causes harms or benefits among dialysis patients. Unlike the inverse relationship of peridialytic BP with mortality, elevated BP recorded outside of dialysis is directly associated with poor long-term outcomes. Apart from the timing and technique of BP measurement, the U-shaped association of BP with mortality is also modified when accounting for factors related to patient's clinical characteristics and level of illness, dialysis practices, and patterns as well as factors related to the methodology of survival analysis. Most importantly, deliberate BP lowering with antihypertensive drugs is associated with reduced cardiovascular morbidity and mortality. In this review, we explore the complex association of peridialytic, intradialytic, and interdialytic BP with outcomes among dialysis patients. We conclude with recommendations for a wider use of out-of-dialysis BP monitoring as a tool to better evaluate the cardiovascular risk and optimize the management of hypertension in this high-risk population. Rather than more cohort studies, we call for randomized trials to test the level of BP in dialysis patients that is optimal for cardiovascular outcomes.",
keywords = "Ambulatory blood pressure monitoring, Blood pressure, Dialysis, Epidemiology, Hypertension, Morbidity, Mortality, Randomized controlled trials",
author = "Georgianos, {Panagiotis I.} and Rajiv Agarwal",
year = "2017",
doi = "10.1093/ajh/hpw114",
language = "English (US)",
volume = "30",
pages = "211--222",
journal = "American Journal of Hypertension",
issn = "0895-7061",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Blood pressure and mortality in long-term hemodialysis-time to move forward

AU - Georgianos, Panagiotis I.

AU - Agarwal, Rajiv

PY - 2017

Y1 - 2017

N2 - Contrary to the direct, graded, and causal relationship of hypertension with cardiovascular outcomes in the general population, among dialysis patients, blood pressure (BP) recorded either predialysis or postdialysis displays a U-shaped curve with mortality. This paradoxical phenomenon of lower BP or a decline in BP over time being associated with increased mortality and higher BP being associated with a lower mortality is described as reverse epidemiology of hypertension, raising substantial controversy on whether BP lowering causes harms or benefits among dialysis patients. Unlike the inverse relationship of peridialytic BP with mortality, elevated BP recorded outside of dialysis is directly associated with poor long-term outcomes. Apart from the timing and technique of BP measurement, the U-shaped association of BP with mortality is also modified when accounting for factors related to patient's clinical characteristics and level of illness, dialysis practices, and patterns as well as factors related to the methodology of survival analysis. Most importantly, deliberate BP lowering with antihypertensive drugs is associated with reduced cardiovascular morbidity and mortality. In this review, we explore the complex association of peridialytic, intradialytic, and interdialytic BP with outcomes among dialysis patients. We conclude with recommendations for a wider use of out-of-dialysis BP monitoring as a tool to better evaluate the cardiovascular risk and optimize the management of hypertension in this high-risk population. Rather than more cohort studies, we call for randomized trials to test the level of BP in dialysis patients that is optimal for cardiovascular outcomes.

AB - Contrary to the direct, graded, and causal relationship of hypertension with cardiovascular outcomes in the general population, among dialysis patients, blood pressure (BP) recorded either predialysis or postdialysis displays a U-shaped curve with mortality. This paradoxical phenomenon of lower BP or a decline in BP over time being associated with increased mortality and higher BP being associated with a lower mortality is described as reverse epidemiology of hypertension, raising substantial controversy on whether BP lowering causes harms or benefits among dialysis patients. Unlike the inverse relationship of peridialytic BP with mortality, elevated BP recorded outside of dialysis is directly associated with poor long-term outcomes. Apart from the timing and technique of BP measurement, the U-shaped association of BP with mortality is also modified when accounting for factors related to patient's clinical characteristics and level of illness, dialysis practices, and patterns as well as factors related to the methodology of survival analysis. Most importantly, deliberate BP lowering with antihypertensive drugs is associated with reduced cardiovascular morbidity and mortality. In this review, we explore the complex association of peridialytic, intradialytic, and interdialytic BP with outcomes among dialysis patients. We conclude with recommendations for a wider use of out-of-dialysis BP monitoring as a tool to better evaluate the cardiovascular risk and optimize the management of hypertension in this high-risk population. Rather than more cohort studies, we call for randomized trials to test the level of BP in dialysis patients that is optimal for cardiovascular outcomes.

KW - Ambulatory blood pressure monitoring

KW - Blood pressure

KW - Dialysis

KW - Epidemiology

KW - Hypertension

KW - Morbidity

KW - Mortality

KW - Randomized controlled trials

UR - http://www.scopus.com/inward/record.url?scp=85016173518&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016173518&partnerID=8YFLogxK

U2 - 10.1093/ajh/hpw114

DO - 10.1093/ajh/hpw114

M3 - Review article

VL - 30

SP - 211

EP - 222

JO - American Journal of Hypertension

JF - American Journal of Hypertension

SN - 0895-7061

IS - 3

ER -